Predictive role of Selvester QRS score in patients undergoing transcatheter aortic valve replacement

被引:2
|
作者
Bignoto, Tiago Costa [1 ]
Le Bihan, David [1 ]
de Mattos Barretto, Rodrigo Bellio [1 ]
de Oliveira Ramos, Auristela Isabel [1 ]
Moreira, Dalmo Antonio Ribeiro [1 ]
Simonato, Matheus [1 ]
de Alvim Siqueira, Dimytri Alexandre [1 ]
Pinto, Ibraim Masciarelli Francisco [1 ]
dos Santos, Tiago Senra Garcia [1 ]
de Moraes Rego Sousa, Amanda Guerra [1 ]
Abizaid, Alexandre [1 ]
机构
[1] Dante Pazzanese Inst Cardiol, 500 Doctor Dante Pazzanese Ave, Sao Paulo, SP, Brazil
关键词
aortic stenosis; mortality; myocardial fibrosis; Selvester QRS score; transaortic valve replacement;
D O I
10.1002/ccd.28905
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Few data exist regarding the late clinical impact of the Selvester score prediction of myocardial fibrosis after transcatheter aortic valve replacement (TAVR). This study evaluated the predictive power of the Selvester score on survival in patients with aortic stenosis (AS) undergoing TAVR. methods and results Patients with severe AS who had preoperative electrocardiograms were included. Clinical follow-up was obtained retrospectively. The primary endpoint was all-cause mortality. Secondary endpoints were cardiovascular death and major adverse cardiac events (MACEs). Two-hundred twenty-eight patients were included (mean age, 81.5 +/- 7.4 years; women, 58.3%). Deceased patients had a higher mean score (4.6 +/- 3.2 vs. 1.4 +/- 1.3; p < .001). At a mean follow-up of 36.2 +/- 21.2 months, the Selvester score was independently associated with all-cause mortality (hazard ratio [HR], 1.65; 95% confidence interval [CI], 1.48-1.84; p < .001), cardiovascular death (HR, 1.59; 95% CI, 1.38-1.74; p < .001), and MACE (HR, 1.55; 95% CI, 1.30-1.68; p < .001). After 5 years, the mortality risk was incrementally related to the Selvester score. The involvement of the inferior wall of the left ventricle was a lower mortality risk factor (HR, 0.42; 95% CI, 0.18-0.98; p = .046). For a Selvester score of 3, the area under the curve showed 0.92, 0.94, and 0.86 (p < .001), respectively, for 1, 2, and 3 years. conclusions Elevated Selvester scores increase the risk of poor outcomes in patients with AS undergoing TAVR. The involvement of the anterior or lateral wall presents worse prognosis.
引用
收藏
页码:E95 / E103
页数:9
相关论文
共 50 条
  • [21] Sarcopenia and frailty in patients undergoing transcatheter aortic valve replacement
    Persits, Ian
    Mirzai, Saeid
    Sarnaik, Kunaal S.
    Volk, Maximilian C.
    Yun, James
    Harb, Serge
    Puri, Rishi
    Kapadia, Samir
    Krishnaswamy, Amar
    Chen, Po-Hao
    Reed, Grant
    Tang, W. H. Wilson
    AMERICAN HEART JOURNAL, 2024, 276 : 49 - 59
  • [22] Racial Disparities in Patients Undergoing Transcatheter Aortic Valve Replacement
    Baibars, Motaz M.
    Al-Khadra, Yasser
    Darmoch, Fahed
    Pacha, Homam Moussa
    Soud, Mohamad
    Alraies, M. Chadi M.
    CIRCULATION, 2019, 140
  • [23] Impact of smoking in patients undergoing transcatheter aortic valve replacement
    Agarwal, Manyoo
    Agrawal, Sahil
    Garg, Lohit
    Reed, Guy L.
    Khouzam, Rami N.
    Ibebuogu, Uzoma N.
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (01)
  • [24] Coronary Revascularization in Patients Undergoing Transcatheter Aortic Valve Replacement
    Finn, Matthew T.
    Nazif, Tamim M.
    Fried, Justin
    Labbe, Benoit M.
    Mohammadi, Siamak
    Leon, Martin B.
    Kodali, Susheel K.
    Rodes-Cabau, Josep
    Paradis, Jean-Michel
    CANADIAN JOURNAL OF CARDIOLOGY, 2017, 33 (09) : 1099 - 1109
  • [25] Protamine in Patients Undergoing Transcatheter Aortic Valve Replacement Why Not?
    ten Berg, Jurrien M.
    Brouwer, Jorn
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (12) : 1481 - 1483
  • [26] Deoxyribonuclease is prognostic in patients undergoing transcatheter aortic valve replacement
    Mangold, Andreas
    Ondracek, Anna S.
    Hofbauer, Thomas M.
    Artner, Tyler
    Nechvile, Johanna
    Panagiotides, Noel G.
    Mirna, Moritz
    Hammerer, Matthias
    Fejzic, Dzeneta
    Hoppe, Uta
    Wernly, Bernhard
    Lauten, Alexander
    Alushi, Brunilda
    Franz, Marcus
    Schulze, Paul C.
    Wohlschlaeger-Krenn, Evelyne
    Lang, Irene M.
    Lichtenauer, Michael
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 (11)
  • [27] Outcomes of Cancer Patients Undergoing Transcatheter Aortic Valve Replacement
    Jain, Vardhmaan
    Saad, Anas M.
    Gad, Mohamed M.
    Bansal, Agam
    Abdelfattah, Omar
    Farwati, Medhat
    Ahuja, Keerat Rai
    Yun, James
    Krishnaswamy, Amar
    Kapadia, Samir R.
    JACC: CARDIOONCOLOGY, 2020, 2 (03): : 506 - 508
  • [28] Antithrombotic therapy in patients undergoing transcatheter aortic valve replacement
    Han, Yaling
    EUROPEAN HEART JOURNAL, 2022, 43 (43) : 4532 - 4533
  • [29] The prognostic value of fragmented QRS in patients undergoing transcatheter aortic valve implantation
    Ay, Nuray Kahraman
    Enhos, Asim
    Ay, Yasin
    Bakhshaliyev, Nijad
    Nadir, Aydin
    Karacop, Erdem
    Celikkale, Ilke
    Uluganyan, Mahmut
    Ozdemir, Razaman
    Goktekin, Omer
    JOURNAL OF ELECTROCARDIOLOGY, 2018, 51 (06) : 923 - 927
  • [30] Syncope in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement
    Keller, Lukas S.
    Nuche, Jorge
    Mesnier, Jules
    Farjat-Pasos, Julio
    De Larochelliere, Robert
    Mohammadi, Siamak
    Kalavrouziotis, Dimitri
    Dumont, Eric
    Philippon, Francois
    Rodes-Cabau, Josep
    CANADIAN JOURNAL OF CARDIOLOGY, 2023, 39 (07) : 901 - 908